Antibody breakthrough could save artificial joints from infection
Disease control
Recruiting now
This study is testing whether a new antibody drug called TRL1068 can help treat chronic infections in artificial hip or knee joints. The goal is to clear the infection while keeping the original artificial joint in place, avoiding the need for a major two-stage replacement surger…
Phase: PHASE2 • Sponsor: Trellis Bioscience LLC • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC